Original language | English |
---|---|
Pages (from-to) | e154-e155 |
Journal | The Lancet Rheumatology |
Volume | 4 |
Issue number | 3 |
Early online date | 23 Dec 2021 |
DOIs |
|
Publication status | Published - 1 Mar 2022 |
Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
Research output: Contribution to journal › Comment/Letter to the editor › Academic
20
Citations
(Scopus)